Kangmei Pharmaceutical Co., Ltd. (600518)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
1. 36
+0.02
+1.4925%
¥
29.53B Market Cap
- P/E Ratio
0.1% Div Yield
128.34M Volume
- Eps
¥ 1.34
Previous Close Want to track 600518 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | 0.17 |
| | | - | 0.18 |
| | | - | 0.22 |
| | | - | 0.15 |
| | | - | 0.15 |
| | | - | 0.14 |
| | | - | 0.19 |
| | | - | 0.18 |
| | | - | 0.11 |
| | | - | 0.1 |
| | | - | 0.13 |
| | | - | 0.11 |
| | | - | 0.1 |
| | | - | 0.09 |
| | | - | 0.13 |
| | | - | 0.1 |
600518 Earnings Reports FAQ
What is the earnings per share (EPS) for 600518?
EPS data for 600518 is currently not available, as Kangmei Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 19.06%, reflecting the 600518's performance and SSE market conditions.
When is the next earnings release date?
Kangmei Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kangmei Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600518 at this time, as Kangmei Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
